|
Addrenex Pharmaceuticals is based in Durham, NC on the edge of Research Triangle Park. Addrenex is a focused, specialty pharmaceutical company that develops drugs to regulate the adrenergic system. The company was founded in 2006 by a drug development expert and a practicing physician. Addrenex identified adrenergic regulation because expertise of the founders and the large number of medical conditions that are affected by a dysfunctional adrenergic system.
Learn more >>
|
May 13, 2009 - Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy
April 23, 2009 - Addrenex Pharmaceuticals Reports Positive Results in Second Phase 3 Study of ADHD Medication
October 24, 2008 - Addrenex Pharmaceuticals initiates phase 2 trial on its novel hypertension drug, ADX415.
Learn more >>
|
Addrenex Pharmaceuticals currently has 4 products in clinical trials and a library of compounds available for future development. Click here to read more about the Addrenex pipeline products;
Learn more >>
|
